Form 4: DENTSPLY SIRONA Director Boosts RSU Holdings

DENTSPLY SIRONA Director Gregory T. Lucier reported an acquisition of 341.114 common stock units through RSU dividends.

Summary

• Gregory T. Lucier, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 341.114 shares of common stock.
• The acquisition occurred on January 9, 2026, and represents dividends on restricted stock units (RSUs).
• These additional RSUs are subject to the same vesting terms as the underlying awards and vest simultaneously.
• Each RSU converts to common stock on a 1:1 basis.
• Following this transaction, Lucier beneficially owns 24,901.284 shares indirectly through a Family Partnership and 21,000 shares indirectly through his IRA.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction where a director received additional restricted stock units as dividends. While not a direct purchase, it increases the insider's beneficial ownership, which can be viewed as a minor positive signal of alignment with shareholder interests. It's a standard compensation event, not indicative of major operational changes.

Positives

• An insider (Director) increasing their beneficial ownership, even through RSU dividends, can be seen as a positive signal of confidence in the company's future.
• The acquisition of additional RSUs at a $0 price indicates a non-cash award, which is a common form of executive compensation.

Risks

• The value of the acquired RSUs is subject to the future performance of DENTSPLY SIRONA's common stock.
• The RSUs are subject to vesting terms, meaning they are not immediately fully owned and can be forfeited if vesting conditions are not met.

Future Outlook

The filing indicates that the newly acquired restricted stock units (RSUs) are subject to the same vesting terms as the underlying awards, implying future ownership is contingent on continued service or performance as per the RSU plan.

Industry Context

This is a routine insider transaction filing (Form 4) for a director receiving equity compensation. Such filings are common across all industries for publicly traded companies, reflecting standard practices for executive and director remuneration, often tied to long-term incentives.

Comparison to Industry Standards

• The acquisition of restricted stock units (RSUs) as a form of equity compensation, including dividends on existing RSUs, is a standard practice for directors and executives in publicly traded companies across various sectors.
• Companies like Johnson & Johnson, Medtronic, and Stryker, which operate in related healthcare or medical device industries, commonly utilize RSUs as part of their long-term incentive plans to align management interests with shareholder value.
• The specific number of units awarded is typically determined by the company's compensation committee based on performance, tenure, and market benchmarks for director compensation.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders through greater equity ownership, albeit through compensation rather than open market purchase.
• Employees: No direct impact on general employees, but reflects standard equity compensation practices for leadership.

Next Steps

• The acquired restricted stock units (RSUs) will vest according to the terms of the underlying awards.
• Upon vesting, each RSU will convert to one share of DENTSPLY SIRONA common stock.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction where a director received additional restricted stock units as dividends. It is a standard compensation event and does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The increase in beneficial ownership, while positive for insider alignment, is not significant enough to alter the overall investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific filing.

Keywords

DENTSPLY SIRONA, XRAY, Insider Trading, Form 4, Director, Restricted Stock Units, RSU, Equity Compensation, Stock Acquisition, Beneficial Ownership